Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

Developments in our understanding of the effects of growth hormone on white adipose tissue from mice: implications to the clinic.

Berryman DE, Henry B, Hjortebjerg R, List EO, Kopchick JJ.

Expert Rev Endocrinol Metab. 2016;11(2):197-207. doi: 10.1586/17446651.2016.1147950. Epub 2016 Feb 24.

2.

The Relationship between the Growth Hormone/Insulin-like Growth Factor System and the Histological Features of Nonalcoholic Fatty Liver Disease.

Chishima S, Kogiso T, Matsushita N, Hashimoto E, Tokushige K.

Intern Med. 2017;56(5):473-480. doi: 10.2169/internalmedicine.56.7626. Epub 2017 Mar 1.

3.

Growth hormone receptor expression in human gluteal versus abdominal subcutaneous adipose tissue: Association with body shape.

Karastergiou K, Bredella MA, Lee MJ, Smith SR, Fried SK, Miller KK.

Obesity (Silver Spring). 2016 May;24(5):1090-1096. doi: 10.1002/oby.21460. Epub 2016 Mar 26.

4.

The effect of recombinant human growth hormone with or without rosiglitazone on hepatic fat content in HIV-1-infected individuals: a randomized clinical trial.

Kotler DP, He Q, Engelson ES, Albu JB, Glesby MJ.

Antivir Ther. 2016;21(2):107-16. doi: 10.3851/IMP2927. Epub 2014 Dec 23.

5.

Effects of recombinant human growth hormone (rhGH) administration on body composition and cardiovascular risk factors in obese adolescent girls.

Slattery M, Bredella MA, Stanley T, Torriani M, Misra M.

Int J Pediatr Endocrinol. 2014;2014(1):22. doi: 10.1186/1687-9856-2014-22. Epub 2014 Nov 15.

6.

Relationship between serum IGF-1 and skeletal muscle IGF-1 mRNA expression to phosphocreatine recovery after exercise in obese men with reduced GH.

Hamarneh SR, Murphy CA, Shih CW, Frontera W, Torriani M, Irazoqui JE, Makimura H.

J Clin Endocrinol Metab. 2015 Feb;100(2):617-25. doi: 10.1210/jc.2014-2711. Epub 2014 Nov 6.

7.

Off-label use of hormones as an antiaging strategy: a review.

Samaras N, Papadopoulou MA, Samaras D, Ongaro F.

Clin Interv Aging. 2014 Jul 23;9:1175-86. doi: 10.2147/CIA.S48918. eCollection 2014. Review.

8.

Effects of GH on body composition and cardiovascular risk markers in young men with abdominal obesity.

Bredella MA, Gerweck AV, Lin E, Landa MG, Torriani M, Schoenfeld DA, Hemphill LC, Miller KK.

J Clin Endocrinol Metab. 2013 Sep;98(9):3864-72. doi: 10.1210/jc.2013-2063. Epub 2013 Jul 3.

9.

Effects of growth hormone withdrawal in obese premenopausal women.

Lin E, Bredella MA, Gerweck AV, Landa M, Schoenfeld D, Utz AL, Miller KK.

Clin Endocrinol (Oxf). 2013 Jun;78(6):914-9. doi: 10.1111/cen.12102.

10.

Reduction in visceral adiposity is associated with an improved metabolic profile in HIV-infected patients receiving tesamorelin.

Stanley TL, Falutz J, Marsolais C, Morin J, Soulban G, Mamputu JC, Assaad H, Turner R, Grinspoon SK.

Clin Infect Dis. 2012 Jun;54(11):1642-51. doi: 10.1093/cid/cis251. Epub 2012 Apr 10.

11.

Effects of GH in women with abdominal adiposity: a 6-month randomized, double-blind, placebo-controlled trial.

Bredella MA, Lin E, Brick DJ, Gerweck AV, Harrington LM, Torriani M, Thomas BJ, Schoenfeld DA, Breggia A, Rosen CJ, Hemphill LC, Wu Z, Rifai N, Utz AL, Miller KK.

Eur J Endocrinol. 2012 Apr;166(4):601-11. doi: 10.1530/EJE-11-1068. Epub 2012 Jan 24.

12.

Contributions of adipocyte lipid metabolism to body fat content and implications for the treatment of obesity.

Marcelin G, Chua S Jr.

Curr Opin Pharmacol. 2010 Oct;10(5):588-93. doi: 10.1016/j.coph.2010.05.008. Epub 2010 Jun 8. Review.

13.

The relationship between reduced testosterone, stimulated growth hormone secretion and increased carotid intima-media thickness in obese men.

Makimura H, Stanley TL, Sun N, Connelly JM, Hemphill LC, Grinspoon SK.

Clin Endocrinol (Oxf). 2010 Nov;73(5):622-9. doi: 10.1111/j.1365-2265.2010.03859.x.

14.

Reduced growth hormone secretion is associated with increased carotid intima-media thickness in obesity.

Makimura H, Stanley T, Mun D, Chen C, Wei J, Connelly JM, Hemphill LC, Grinspoon SK.

J Clin Endocrinol Metab. 2009 Dec;94(12):5131-8. doi: 10.1210/jc.2009-1295. Epub 2009 Oct 16.

15.

Role of growth hormone, insulin-like growth factor 1 and insulin-like growth factor-binding protein 3 in development of non-alcoholic fatty liver disease.

Ichikawa T, Nakao K, Hamasaki K, Furukawa R, Tsuruta S, Ueda Y, Taura N, Shibata H, Fujimoto M, Toriyama K, Eguchi K.

Hepatol Int. 2007 Jun;1(2):287-94. doi: 10.1007/s12072-007-9007-4. Epub 2007 Jun 1.

16.

Peak growth hormone-releasing hormone-arginine-stimulated growth hormone is inversely associated with intramyocellular and intrahepatic lipid content in premenopausal women with obesity.

Bredella MA, Torriani M, Thomas BJ, Ghomi RH, Brick DJ, Gerweck AV, Miller KK.

J Clin Endocrinol Metab. 2009 Oct;94(10):3995-4002. doi: 10.1210/jc.2009-0438. Epub 2009 Jul 14.

17.

Growth hormone and sex steroid effects on serum glucose, insulin, and lipid concentrations in healthy older women and men.

Münzer T, Harman SM, Sorkin JD, Blackman MR.

J Clin Endocrinol Metab. 2009 Oct;94(10):3833-41. doi: 10.1210/jc.2009-1275. Epub 2009 Jul 14.

18.

Effects of exercise training intensity on nocturnal growth hormone secretion in obese adults with the metabolic syndrome.

Irving BA, Weltman JY, Patrie JT, Davis CK, Brock DW, Swift D, Barrett EJ, Gaesser GA, Weltman A.

J Clin Endocrinol Metab. 2009 Jun;94(6):1979-86. doi: 10.1210/jc.2008-2256. Epub 2009 Mar 24.

19.

Anthropometry, CT, and DXA as predictors of GH deficiency in premenopausal women: ROC curve analysis.

Bredella MA, Utz AL, Torriani M, Thomas B, Schoenfeld DA, Miller KK.

J Appl Physiol (1985). 2009 Feb;106(2):418-22. doi: 10.1152/japplphysiol.90998.2008. Epub 2008 Dec 18.

20.

Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: a randomized trial.

Nass R, Pezzoli SS, Oliveri MC, Patrie JT, Harrell FE Jr, Clasey JL, Heymsfield SB, Bach MA, Vance ML, Thorner MO.

Ann Intern Med. 2008 Nov 4;149(9):601-11.

Supplemental Content

Support Center